Argenica strengthens the clinical case for neuroprotective drug candidate ARG-007 with new independently generated preclinical stroke data. ... Read More The post New preclinical study validates ...

Jeremy has more than 2100 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

Niger has accused French nuclear fuel group Orano of "predatory behavior" and environmental crimes, escalating a bitter ...

CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive ...

This backgrounder provides an overview of the Axis of Resistance, a loosely aligned network of armed groups and state actors ...

One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed cell death, through changes in ...

We'll highlight a different cause every week. ‘That Has Never Been Tolerated in the Entire History of Our Republic’ Warren Buffett suggests all parents do one thing before they die, whether they have ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit.

Inhibitory receptors have increasingly been recognized as critical players in the maintenance of immune homeostasis. These receptors, expressed on a variety ...